These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Poor outcome and low platelet MAO activity in chronic schizophrenia. Bierer L; Docherty JP; Young JG; Giller E; Cohen D Am J Psychiatry; 1984 Feb; 141(2):257-60. PubMed ID: 6140867 [TBL] [Abstract][Full Text] [Related]
12. Comparison of monoamine oxidase substrate activities in twins, schizophrenics, depressives, and controls. Nies A; Robinson DS; Harris LS; Lamborn KR Adv Biochem Psychopharmacol; 1974; 12(0):59-70. PubMed ID: 4607593 [No Abstract] [Full Text] [Related]
13. Kinetic aspects of monoamine oxidase activity in twins with psychoses. Koide Y; Eberhard G; Sääf J; Ross SB; Wahlund LO; Wetterberg L Clin Genet; 1981 May; 19(5):395-400. PubMed ID: 6945925 [TBL] [Abstract][Full Text] [Related]
14. Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients. Schildkraut JJ; Herzog JM; Orsulak PJ; Edelman SE; Shein HM; Frazier SH Am J Psychiatry; 1976 Apr; 133(4):438-40. PubMed ID: 1267046 [TBL] [Abstract][Full Text] [Related]
15. Platelet MAO activity in schizophrenia and other psychiatric illnesses. Sullivan J; Stanfield CN; Dackis C Am J Psychiatry; 1977 Oct; 134(10):1098-1103. PubMed ID: 900261 [TBL] [Abstract][Full Text] [Related]
16. Reduction of blood platelet monoamine oxidase activity in schizophrenic patients on phenothiazines. Takahashi S; Yamane H; Tani N Folia Psychiatr Neurol Jpn; 1975; 29(3):207-14. PubMed ID: 2524 [TBL] [Abstract][Full Text] [Related]